Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 68071-2285

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 68071-2285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2285 6)

Label for Pantoprazole Sodium 20 mg delayed-release tablets from NuCare Pharmaceuticals, Inc., containing 60 tablets. The label indicates dosage form as enteric-coated tablets, oval in shape, yellow to pale yellow, imprinted with 'H125'. It includes instructions to take one tablet orally daily and storage conditions at 68-77°F, with warnings to keep out of reach of children.*

FDA Label Image

Address1.jpg (Address1)

FDA Label Image

Address2.jpg (Address2)

FDA Label Image

Structure.jpg (Structure)

Chemical structure diagram of pantoprazole showing its molecular components, including fluorinated groups and sodium ion, consistent with the active ingredient pantoprazole in PANTOPRAZOLE SODIUM tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.